Last updated on September 2018

Clinical Study of S-649266 for the Treatment of Nosocomial Pneumonia Caused by Gram-negative Pathogens

Brief description of study

To compare all-cause mortality at Day 14 in participants receiving S-649266 with participants receiving the comparator, meropenem, in adults with hospital-acquired bacterial pneumonia (HABP), ventilator-associated bacterial pneumonia (VABP), or healthcare-associated bacterial pneumonia (HCABP) caused by Gram-negative pathogens.

Clinical Study Identifier: NCT03032380

Contact Investigators or Research Sites near you

Start Over

Shionogi Clinical Trials Administrator Clinical ...

Shionogi Research Site
Batumi, Georgia
  Connect »